Cargando…

Cellular mechanisms underlying steroid-resistant asthma

Severe steroid-resistant asthma is clinically important, as patients with this form of the disease do not respond to mainstay corticosteroid therapies. The heterogeneity of this form of asthma and poor understanding of the pathological mechanisms involved hinder the identification of therapeutic tar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wadhwa, Ridhima, Dua, Kamal, Adcock, Ian M., Horvat, Jay C., Kim, Richard Y., Hansbro, Philip M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Lung Science Conference Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488801/ https://www.ncbi.nlm.nih.gov/pubmed/31636089 http://dx.doi.org/10.1183/16000617.0096-2019

Ejemplares similares

The ageing lung under stress
por: Korfei, Martina, et al.
Publicado: (2020)

Steroid resistance and concomitant respiratory infections: A challenging battle in pulmonary clinic
por: Dua, Kamal, et al.
Publicado: (2017)

Cytokine-targeted therapies for asthma and COPD
por: Schleich, Florence, et al.
Publicado: (2023)

The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
por: Invernizzi, Rachele, et al.
Publicado: (2019)

Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives
por: Chelladurai, Prakash, et al.
Publicado: (2016)

Immune checkpoints in chronic obstructive pulmonary disease
por: Wilkinson, Tom M.A.
Publicado: (2017)

Mitochondrial dysfunction in lung ageing and disease
por: Cloonan, Suzanne M., et al.
Publicado: (2020)

Understanding the mechanisms of viral induced asthma: New therapeutic directions
por: Hansbro, Nicole G., et al.
Publicado: (2008)

Intersections of lung progenitor cells, lung disease and lung cancer
por: Kim, Carla F.
Publicado: (2017)

Matrix abnormalities in pulmonary fibrosis
por: Upagupta, Chandak, et al.
Publicado: (2018)

Cell therapy for lung disease
por: Geiger, Sabine, et al.
Publicado: (2017)

Shared epithelial pathways to lung repair and disease
por: Spella, Magda, et al.
Publicado: (2017)

Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
por: Lai, Rocky, et al.
Publicado: (2015)

Acellular human lung scaffolds to model lung disease and tissue regeneration
por: Gilpin, Sarah E., et al.
Publicado: (2018)

Therapeutic strategies in pneumonia: going beyond antibiotics
por: Müller-Redetzky, Holger, et al.
Publicado: (2015)

Macrophage adaptation in airway inflammatory resolution
por: Kaur, Manminder, et al.
Publicado: (2015)

The heterogeneity of lung macrophages in the susceptibility to disease
por: Morales-Nebreda, Luisa, et al.
Publicado: (2015)

The exposome concept: a challenge and a potential driver for environmental health research
por: Siroux, Valérie, et al.
Publicado: (2016)

Natural experiments and large databases in respiratory and cardiovascular disease
por: Vestbo, Jørgen
Publicado: (2016)

The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease
por: Patel, Dhiren F., et al.
Publicado: (2018)

Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
por: Zheng, Xiang, et al.
Publicado: (2020)

Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
por: Vandeplassche, Eva, et al.
Publicado: (2019)

How bacteria hack the matrix and dodge the bullets of immunity
por: Paulsson, Magnus, et al.
Publicado: (2018)

Endoplasmic reticulum stress in lung disease
por: Marciniak, Stefan J.
Publicado: (2017)

Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome
por: Robinson, Matthew John, et al.
Publicado: (2020)

Respiratory muscle senescence in ageing and chronic lung diseases
por: Gea, Joaquim, et al.
Publicado: (2020)

The consequence of matrix dysfunction on lung immunity and the microbiome in COPD
por: Hussell, Tracy, et al.
Publicado: (2018)

Particulate matter and the airway epithelium: the special case of the underground?
por: Cooper, Dawn M., et al.
Publicado: (2019)

PULSE-DOSE STEROIDS FOR USE IN PULMONARY FIBROSIS RELATED TO COVID-19 INFECTION
por: BRADY, JAMES, et al.
Publicado: (2021)

The microbiome in bronchiectasis
por: Richardson, Hollian, et al.
Publicado: (2019)

A role for club cells in smoking-associated lung adenocarcinoma
por: Behrend, Sabine J., et al.
Publicado: (2021)

Chronic lung diseases: entangled in extracellular matrix
por: Burgess, Janette K., et al.
Publicado: (2022)

Cellular Therapy in NSCLC: Between Myth and Reality
por: Imbimbo, Martina, et al.
Publicado: (2023)

Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation
por: Naik, Chetan, et al.
Publicado: (2018)

Asthma-COPD overlap: current understanding and the utility of experimental models
por: Tu, Xiaofan, et al.
Publicado: (2021)

Elucidating novel disease mechanisms in severe asthma
por: Kim, Richard Y, et al.
Publicado: (2016)

EXTENSION OF STEROID THERAPY FOR POST-COVID-19 FIBROTIC LUNG SEQUALAE
por: TOUMAN, A., et al.
Publicado: (2022)

Plasma Donor-derived Cell-free DNA Levels Are Increased During Acute Cellular Rejection After Lung Transplant: Pilot Data
por: Sayah, David, et al.
Publicado: (2020)

Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
por: Paudel, Keshav Raj, et al.
Publicado: (2020)

Barriers to identifying occupational asthma among primary healthcare professionals: a qualitative study
por: Walters, Gareth I, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vlspoeb947pcgbppuvtok1f7qd